CLRB Shares Outstanding History



Below is a table of the CLRB shares outstanding history going back to 3/7/2016:

Date CLRB Shares Outstanding
3/7/20168581
4/29/201637324
5/10/201638324
8/8/201653682
10/14/201653682
11/7/201653682
3/10/2017128379
5/8/2017134622
8/9/2017139222
11/9/2017158140
3/15/2018173883
5/7/2018173883
7/17/2018173883
8/8/2018359532
11/9/2018475779
2/22/2019475771
5/1/2019531521
8/5/2019939604
11/7/2019939604
2/24/2020939602
5/4/2020939602
8/6/20202.66M
11/4/20202.68M
3/1/20215.05M
4/26/20215.27M
5/5/20215.27M
8/4/20216.11M
11/5/20216.11M
3/18/20226.11M
5/6/20226.11M
8/2/20226.11M
10/31/20229.39M
3/3/20239.74M
5/2/20239.74M
8/9/20239.74M
11/10/202312.29M
3/21/202432.26M

Also see: CLRB Market Cap History
CLRB YTD Return
CLRB Historical Shares Outstanding:
+178.36% CAGR
CLRB Historical Shares Outstanding: +178.36% CAGR

Mouse over chart for data details
3/7/2016 ...3/21/2024
Cellectar Biosciences is a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer. Co.'s phospholipid drug conjugate (PDC) therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells. Co.'s product pipeline also includes one preclinical PDC chemotherapeutic program (CLR 1900) and several partnered PDC assets. The CLR 1900 Series is being developed for solid tumors with a payload that inhibits mitosis a validated pathway for treating cancers. We show 37 historical shares outstanding datapoints in our coverage of CLRB's shares outstanding history.

Understanding the changing numbers of CLRB shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CLRB versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CLRB by allowing them to research CLRB shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree CLRB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cellectar Biosciences (CLRB) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

CLSD Shares Outstanding History
CLSN Shares Outstanding History
CLVS Shares Outstanding History
CLXT Shares Outstanding History
CMAX Shares Outstanding History
CMD Shares Outstanding History
CMPI Shares Outstanding History
CMPX Shares Outstanding History
CMRA Shares Outstanding History
CMRX Shares Outstanding History
More Healthcare companies »

 

CLRB Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.